Millennium Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.7M | Buy |
3,281,820
+102,957
| +3% | +$479K | 0.01% | 1806 |
|
|
2025
Q4 | $17.5M | Sell |
3,178,863
-847,259
| -21% | -$4.11M | 0.01% | 1708 |
|
|
2025
Q3 | $13.2M | Buy |
4,026,122
+1,090,394
| +37% | +$3.09M | 0.01% | 2097 |
|
|
2025
Q2 | $6.78M | Buy |
2,935,728
+1,163,074
| +66% | +$2.53M | ﹤0.01% | 2661 |
|
|
2025
Q1 | $2.46M | Buy |
1,772,654
+1,621,040
| +1,069% | +$2.71M | ﹤0.01% | 3582 |
|
|
2024
Q4 | $262K | Buy |
+151,614
| New | +$315K | ﹤0.01% | 5147 |
|
|
2024
Q3 | – | Sell |
-340,724
| Closed | -$763K | – | 6488 |
|
|
2024
Q2 | $763K | Sell |
340,724
-2,794,593
| -89% | -$8.13M | ﹤0.01% | 4304 |
|
|
2024
Q1 | $9M | Sell |
3,135,317
-245,215
| -7% | -$511K | ﹤0.01% | 2290 |
|
|
2023
Q4 | $5.98M | Buy |
+3,380,532
| New | +$6.74M | ﹤0.01% | 2634 |
|
|
2023
Q3 | – | Sell |
-614,938
| Closed | -$1.15M | – | 6579 |
|
|
2023
Q2 | $406K | Buy |
614,938
+137,893
| +29% | +$99.8K | ﹤0.01% | 4679 |
|
|
2023
Q1 | $380K | Buy |
477,045
+90,456
| +23% | +$117K | ﹤0.01% | 4760 |
|
|
2022
Q4 | $874K | Buy |
386,589
+212,211
| +122% | +$430K | ﹤0.01% | 4293 |
|
|
2022
Q3 | $337K | Sell |
174,378
-41,790
| -19% | -$152K | ﹤0.01% | 5272 |
|
|
2022
Q2 | $804K | Buy |
+216,168
| New | +$858K | ﹤0.01% | 4573 |
|
|
2022
Q1 | – | Sell |
-60,049
| Closed | -$700K | – | 7500 |
|
|
2021
Q4 | $700K | Buy |
+60,049
| New | +$906K | ﹤0.01% | 4747 |
|
|
2021
Q3 | – | Sell |
-30,165
| Closed | -$639K | – | 7261 |
|
|
2021
Q2 | $639K | Buy |
30,165
+9,040
| +43% | +$208K | ﹤0.01% | 5088 |
|
|
2021
Q1 | $429K | Buy |
21,125
+1,725
| +9% | +$46.7K | ﹤0.01% | 4943 |
|
|
2020
Q4 | $515K | Sell |
19,400
-153,857
| -89% | -$3.31M | ﹤0.01% | 4170 |
|
|
2020
Q3 | $3.88K | Buy |
+173,257
| New | +$4.08M | ﹤0.01% | 2063 |
|
Other funds holding TSHA
RCM
ACA
VPC
RI
VCM